Occuloplex I
NDC 43857-0600, Euphrasia Officinalis, Ginkgo Biloba, Taraxacum Officinale, Hydrastis Canadensis, Glutathione, Ubidecarenonum, Zincum Gluconicum, Citrus Bioflavonoids, Eye (Suis), Ammonium Muriaticum, Calcarea Fluorica, Causticum, Conium Maculatum, Cyanocobalamin, Germanium Sesquioxide, Magnesia Carbonica, Selenium Dioxide, Silicea, Beta Carotene, liquid, from BioActive Nutritional, Inc..
- Product NDC
- 43857-0600
- Status
- Listed
- Labeler
- BioActive Nutritional, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0600 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EUPHRASIA STRICTA3 [hp_X]/mL
- GINKGO3 [hp_X]/mL
- TARAXACUM OFFICINALE3 [hp_X]/mL
- GOLDENSEAL5 [hp_X]/mL
- GLUTATHIONE6 [hp_X]/mL
- UBIDECARENONE6 [hp_X]/mL
- ZINC GLUCONATE6 [hp_X]/mL
- CITRUS BIOFLAVONOIDS8 [hp_X]/mL
- SUS SCROFA EYE8 [hp_X]/mL
- AMMONIUM CHLORIDE12 [hp_X]/mL
- CALCIUM FLUORIDE12 [hp_X]/mL
- CAUSTICUM12 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP12 [hp_X]/mL
- CYANOCOBALAMIN12 [hp_X]/mL
- GERMANIUM SESQUIOXIDE12 [hp_X]/mL
- MAGNESIUM CARBONATE12 [hp_X]/mL
- SELENIUM DIOXIDE12 [hp_X]/mL
- SILICON DIOXIDE12 [hp_X]/mL
- BETA CAROTENE9 [hp_C]/mL
Pharmacologic classes
Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Vitamin B 12 [CS]; Vitamin B12 [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43857-0600-1 | 43857060001 | 30 mL in 1 BOTTLE, DROPPER (43857-0600-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43857-0600 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0600 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43857-0600. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.